60 Degrees Pharmaceuticals, Inc.
SXTP
$1.75
-$0.11-5.91%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.91M | -1.57M | -735.20K | -3.77M | -3.43M |
| Total Depreciation and Amortization | 71.20K | 81.90K | 95.90K | 100.30K | 98.30K |
| Total Amortization of Deferred Charges | -690.20K | -662.90K | -328.60K | 46.70K | 1.08M |
| Total Other Non-Cash Items | 3.18M | -3.01M | -3.99M | -1.33M | -2.60M |
| Change in Net Operating Assets | 1.28M | -984.00K | -317.70K | 405.30K | 308.90K |
| Cash from Operations | -4.07M | -6.15M | -5.27M | -4.54M | -4.55M |
| Capital Expenditure | -159.60K | -147.60K | -57.60K | -57.60K | -1.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.79M | -87.30K | -64.80K | -58.30K | -106.10K |
| Cash from Investing | -1.95M | -234.90K | -122.40K | -115.90K | -107.90K |
| Total Debt Issued | 0.00 | 0.00 | 700.00K | 900.00K | 1.09M |
| Total Debt Repaid | 0.00 | -1.61M | -1.86M | -1.86M | -1.86M |
| Issuance of Common Stock | 7.15M | 9.51M | 9.51M | 7.59M | 7.59M |
| Repurchase of Common Stock | -- | -- | -- | -- | -185.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -102.10K | -26.00K | -149.00K | -150.40K | -219.00K |
| Cash from Financing | 7.05M | 7.87M | 8.20M | 6.47M | 6.41M |
| Foreign Exchange rate Adjustments | 56.70K | 64.20K | 62.30K | 61.80K | 26.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.08M | 1.56M | 2.86M | 1.88M | 1.78M |
